Prescription drug · NDA
Xpovio (Selinexor) NDC 72237-104
Selinexor 60 mg/1 · Tablet, Film coated · Oral · Karyopharm Therapeutics Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72237-104-01 | 72237010401 | 4 BLISTER PACK in 1 CARTON (72237-104-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK (72237-104-11)Marketed from May 19, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Xpovio
- Generic name (nonproprietary)
- selinexor
- Active ingredients
- Selinexor — 60 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Karyopharm Therapeutics Inc.NDC labeler code 72237
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 212306
- Marketing start
- Listing expires
- Other FDA classes
- Nuclear Export Inhibitors (Mechanism)
- Identifiers
- Product ID 72237-104_5e9b366c-3fc4-4178-bb80-687e21f9beffSPL ID 5e9b366c-3fc4-4178-bb80-687e21f9beffSPL set ID f6dd2682-75a6-4863-90a8-a3197f6f78a8RxCUI 2178395, 2178402, 2178406, 2178407, 2382989, 2382990, 2548732, 2548733, 2548735, 2548736, 2548738, 2548739, 2548741, 2548742, 2548762, 2548763, 2548765, 2548766, 2548767, 2548768, 2548769, 2708335, 2708337, 2708338, 2708339, 2730152, 2730154, 2730155, 2730156UNII 31TZ62FO8FUPC 0372237105118, 0372237101141, 0372237102124, 0372237104111, 0372237102179, 0372237106115, 0372237103152, 0372237106016
- Pharmacologic class
- Nuclear Export Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472237010401followed by a unit qualifier and the quantityPackage 72237-0104-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
XPOVIO is a nuclear export inhibitor indicated: In combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy ( 1.1 ). In combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody ( 1.1 ). 1.1 Multiple Myeloma XPOVIO in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at leas…
Excerpt only. Read the full label for complete information.
About NDC 72237-104
- What is NDC 72237-104?
- 72237-104 is the product NDC for Xpovio (selinexor), Selinexor 60 mg/1 tablet, film coated, listed with the FDA by Karyopharm Therapeutics Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Xpovio (Selinexor).
- What is the active ingredient?
- Selinexor.
- Who is the labeler?
- Karyopharm Therapeutics Inc., NDC labeler code 72237. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Xpovio?
- 5 other product NDCs are listed under this name. See all Xpovio NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Xpovio products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Xpovioselinexor | Selinexor 80 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-105 | 72237-0105-01 |
| Xpovioselinexor | Selinexor 10 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-106 | 72237-0106-01 |
| Xpovioselinexor | Selinexor 40 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-102 | 72237-0102-0272237-0102-0672237-0102-07 |
| Xpovioselinexor | Selinexor 50 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-103 | 72237-0103-05 |
| Xpovioselinexor | Selinexor 20 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-101 | 72237-0101-0372237-0101-04 |
Other NDCs under NDA 212306
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Xpovioselinexor | Selinexor 20 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-101 |
| Xpovioselinexor | Selinexor 40 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-102 |
| Xpovioselinexor | Selinexor 50 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-103 |
| Xpovioselinexor | Selinexor 80 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-105 |
| Xpovioselinexor | Selinexor 10 mg/1 | Tablet, Film coatedOral | Karyopharm Therapeutics Inc. | 72237-106 |